BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Visconti L, Nelissen K, Deckx L, van den Akker M, Adriaensen W, Daniels L, Matheï C, Linsen L, Hellings N, Stinissen P. Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients. Biomark Med. 2014;8:297-306. [PMID: 24521026 DOI: 10.2217/bmm.13.122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Whiteside TL. Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem. 2016;74:103-141. [PMID: 27117662 DOI: 10.1016/bs.acc.2015.12.005] [Cited by in Crossref: 279] [Cited by in F6Publishing: 257] [Article Influence: 55.8] [Reference Citation Analysis]
2 Kobayashi T, Baghdadi M, Han N, Murata T, Hama N, Otsuka R, Wada H, Shiozawa M, Yokose T, Miyagi Y, Takano A, Daigo Y, Seino K. Prognostic value of IL-34 in colorectal cancer patients. Immunological Medicine 2019;42:169-75. [DOI: 10.1080/25785826.2019.1691429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bowyer JF, Tranter KM, Hanig JP, Crabtree NM, Schleimer RP, George NI. Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood. PLoS One 2015;10:e0133315. [PMID: 26177368 DOI: 10.1371/journal.pone.0133315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Song L, Wang S, Fang T, Qiu X, Wang X, Zhou X, Morse MA, Hobeika A, Wu W, Yang H, Ren J, Lyerly HK. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation. Int J Radiat Oncol Biol Phys 2021;111:479-90. [PMID: 33974888 DOI: 10.1016/j.ijrobp.2021.04.041] [Reference Citation Analysis]
5 Svetlovska D, Miskovska V, Cholujova D, Gronesova P, Cingelova S, Chovanec M, Sycova-mila Z, Obertova J, Palacka P, Rajec J, Kalavska K, Usakova V, Luha J, Ondrus D, Spanik S, Mardiak J, Mego M. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients. Clinical Genitourinary Cancer 2017;15:411-416.e2. [DOI: 10.1016/j.clgc.2017.01.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
6 Thålin C, Lundström S, Seignez C, Daleskog M, Lundström A, Henriksson P, Helleday T, Phillipson M, Wallén H, Demers M. Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer.PLoS One. 2018;13:e0191231. [PMID: 29324871 DOI: 10.1371/journal.pone.0191231] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 25.7] [Reference Citation Analysis]
7 Wada NI, Bream JH, Martínez-Maza O, Macatangay B, Galvin SR, Margolick JB, Jacobson LP. Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study. Clin Infect Dis 2016;63:984-90. [PMID: 27343547 DOI: 10.1093/cid/ciw409] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
8 Da Silva DM, Enserro DM, Mayadev JS, Skeate JG, Matsuo K, Pham HQ, Lankes HA, Moxley KM, Ghamande SA, Lin YG, Schilder RJ, Birrer MJ, Kast WM. Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). Clin Cancer Res 2020;26:5621-30. [PMID: 32816895 DOI: 10.1158/1078-0432.CCR-20-0776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lee C, Cheung ST. STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. Cancers (Basel). 2019;11. [PMID: 31731457 DOI: 10.3390/cancers11111646] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
11 Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, Nadella MV, Mohseni M, Lawson D, Reimer C, Blakey DC, Xiao X, Hsu J, Revenko A, Monia BP, MacLeod AR. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci Transl Med 2015;7:314ra185. [PMID: 26582900 DOI: 10.1126/scitranslmed.aac5272] [Cited by in Crossref: 222] [Cited by in F6Publishing: 206] [Article Influence: 44.4] [Reference Citation Analysis]
12 Chaturvedi S, Siegel D, Wagner CL, Park J, van de Velde H, Vermeulen J, Fung MC, Reddy M, Hall B, Sasser K. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6. Br J Clin Pharmacol 2015;80:687-97. [PMID: 25847183 DOI: 10.1111/bcp.12652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]